Skip to main content
Erschienen in: Archives of Gynecology and Obstetrics 1/2020

09.05.2020 | Maternal-Fetal Medicine

Comparison of criteria of International Association of Diabetes and Pregnancy Study Groups (IADPSG) with National Institute for Health and Care Excellence (NICE) for diagnosis of gestational diabetes mellitus

verfasst von: Sushila Todi, Haritha Sagili, Sadish Kumar Kamalanathan

Erschienen in: Archives of Gynecology and Obstetrics | Ausgabe 1/2020

Einloggen, um Zugang zu erhalten

Abstract

Background

Different screening procedures and diagnostic criteria are being followed in the same as well as in different countries with no single standard criteria established for diagnosis of GDM. So far, there are no studies in the Indian population comparing IADPSG with NICE criteria.

Objective

To compare International Association of Pregnancy and Study Groups (IADPSG) criteria with the National Institute for Health and Care Excellence (NICE) for diagnosis of gestational diabetes mellitus and its influence on maternal and perinatal outcomes.

Method

This prospective observational study was conducted in the Department of Obstetrics and Gynaecology of a tertiary care institute in South India from March 2017 to October 2018. Six-hundred and eighty women with or without risk factors for GDM were recruited in the study and screened for GDM based on IADPSG and NICE criteria. Women with preexisting diabetes mellitus or with fasting plasma glucose ≥ 126 mg/dl were excluded.

Results

The overall prevalence of GDM in our study was 27.2% by either IADPSG/NICE criteria. In this study, 25.1% women and 11.6% women were diagnosed as GDM using IADPSG and NICE criteria, respectively. The level of agreement between the two diagnostic criteria was found to be poor in our study and was statistically significant (kappa = 0.429, p < 0.001). Women testing IADPSG-positive NICE-negative had a higher risk of GHTN, abortions, PROM, preterm delivery, caesarean section and congenital anomalies, meconium-stained liquor, and low Apgar scores at 1 min when compared to non GDM group. In addition, except for preterm delivery, women diagnosed as GDM by both IADPSG and NICE criteria had adverse outcomes such as preeclampsia, urinary tract infection, and polyhydramnios. Women diagnosed as GDM in IADPSG-negative NICE-positive had no significant adverse maternal or perinatal outcomes.

Conclusions

IADPSG criteria appear to be more robust than NICE criteria for diagnosis of GDM. Women with substantial risk of maternal and perinatal outcomes are better identified by IADPSG criteria who would have been missed if NICE criteria was used.
Literatur
1.
Zurück zum Zitat American Diabetes Association (2018) Standards of Medical care in diabetes. Diabetes Care 41:S13–S27CrossRef American Diabetes Association (2018) Standards of Medical care in diabetes. Diabetes Care 41:S13–S27CrossRef
2.
Zurück zum Zitat Jiwani A, Marseille E, Lohse N, Damm P, Hod M, Kahn JG (2012) Gestational diabetes mellitus: results from a survey of country prevalence and practices. J Matern Fetal Neonatal Med 25:600–610CrossRef Jiwani A, Marseille E, Lohse N, Damm P, Hod M, Kahn JG (2012) Gestational diabetes mellitus: results from a survey of country prevalence and practices. J Matern Fetal Neonatal Med 25:600–610CrossRef
3.
Zurück zum Zitat Dooley S, Metzger B, Cho NH (1991) Gestational diabetes mellitus: influence of race on disease prevalence and perinatal outcome in a US population. Diabetes 40:25–29CrossRef Dooley S, Metzger B, Cho NH (1991) Gestational diabetes mellitus: influence of race on disease prevalence and perinatal outcome in a US population. Diabetes 40:25–29CrossRef
4.
Zurück zum Zitat Chu SY, Abe K, Hall CR, Kim SY, Njoroge T, Qin C (2009) Gestational diabetes mellitus: All Asians are not alike. Prev Med 4(9):265–268CrossRef Chu SY, Abe K, Hall CR, Kim SY, Njoroge T, Qin C (2009) Gestational diabetes mellitus: All Asians are not alike. Prev Med 4(9):265–268CrossRef
5.
Zurück zum Zitat Li KT, Naik S, Alexander M, Mathad JS (2018) Screening and diagnosis of gestational diabetes in India: a systematic review and meta-analysis. Acta Diabetol 55:613–625CrossRef Li KT, Naik S, Alexander M, Mathad JS (2018) Screening and diagnosis of gestational diabetes in India: a systematic review and meta-analysis. Acta Diabetol 55:613–625CrossRef
6.
Zurück zum Zitat Buchanan TA, Xiang AH, Page KA (2012) Gestational diabetes mellitus: Risks and management during and after pregnancy. Nat Rev Endocrinol 8:639–649CrossRef Buchanan TA, Xiang AH, Page KA (2012) Gestational diabetes mellitus: Risks and management during and after pregnancy. Nat Rev Endocrinol 8:639–649CrossRef
7.
Zurück zum Zitat Farrar D, Simmonds M, Bryant M, Sheldon TA, Tuffnell D, Golder S et al (2016) Hyperglycaemia and risk of adverse perinatal outcomes: systematic review and meta-analysis. BMJ 354:i4694CrossRef Farrar D, Simmonds M, Bryant M, Sheldon TA, Tuffnell D, Golder S et al (2016) Hyperglycaemia and risk of adverse perinatal outcomes: systematic review and meta-analysis. BMJ 354:i4694CrossRef
8.
Zurück zum Zitat Bellamy L, Casas J-P, Hingorani AD, Williams D (2009) Type 2 DM after gestational diabetes: a systematic review and meta- analysis. Lancet 373:1773–1779CrossRef Bellamy L, Casas J-P, Hingorani AD, Williams D (2009) Type 2 DM after gestational diabetes: a systematic review and meta- analysis. Lancet 373:1773–1779CrossRef
9.
Zurück zum Zitat Abourawi FI, ChB M (2006) Diabetes mellitus and pregnancy. Libyan J Med 1:14CrossRef Abourawi FI, ChB M (2006) Diabetes mellitus and pregnancy. Libyan J Med 1:14CrossRef
10.
Zurück zum Zitat Metzger BE, Lowe LP, Dyer AR, Trimble ER, Chaovarindr U, Coustan DR, HAPO Study Cooperative Research Group (2008) Hyperglycemia and adverse pregnancy outcomes. N Engl J Med 358:1991–2002CrossRef Metzger BE, Lowe LP, Dyer AR, Trimble ER, Chaovarindr U, Coustan DR, HAPO Study Cooperative Research Group (2008) Hyperglycemia and adverse pregnancy outcomes. N Engl J Med 358:1991–2002CrossRef
11.
Zurück zum Zitat Metzger BE, Gabbe SG, Persson B, Buchanan TA, Catalano PA, Damm P et al (2010) International Association of Diabetes and Pregnancy Study Groups Consensus Panel. International association of diabetes and pregnancy study groups recommendations on the Diagnosis and Classification of Hyperglycemia in Pregnancy. Diabetes Care 33:676–682CrossRef Metzger BE, Gabbe SG, Persson B, Buchanan TA, Catalano PA, Damm P et al (2010) International Association of Diabetes and Pregnancy Study Groups Consensus Panel. International association of diabetes and pregnancy study groups recommendations on the Diagnosis and Classification of Hyperglycemia in Pregnancy. Diabetes Care 33:676–682CrossRef
12.
Zurück zum Zitat Agarwal M, Coetzee E, Falavigna M, Meltzer SJ, Boulvain M, Colagiuri S et al (2014) Diagnostic criteria and classification of hyperglycemia first detected in pregnancy: a World health Organization Guideline. Diabetes Res Clin Pract 103:341–363CrossRef Agarwal M, Coetzee E, Falavigna M, Meltzer SJ, Boulvain M, Colagiuri S et al (2014) Diagnostic criteria and classification of hyperglycemia first detected in pregnancy: a World health Organization Guideline. Diabetes Res Clin Pract 103:341–363CrossRef
14.
Zurück zum Zitat American Diabetes Association (2014) Standards of Medical care in diabetes. Diabetes Care 37:S14–S80CrossRef American Diabetes Association (2014) Standards of Medical care in diabetes. Diabetes Care 37:S14–S80CrossRef
15.
Zurück zum Zitat Blumer I, Hadar E, Hadden DR, Jovanovic L, Mestman JH, Murad MH et al (2013) Diabetes and pregnancy: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 98:4227–4249CrossRef Blumer I, Hadar E, Hadden DR, Jovanovic L, Mestman JH, Murad MH et al (2013) Diabetes and pregnancy: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 98:4227–4249CrossRef
16.
Zurück zum Zitat Hod M, Kapur A, Sacks DA, Hadar E, Agarwal M, Di Renzo GC et al (2015) The International Federation of Gynecology and Obstetrics Initiative on gestational diabetes mellitus: a pragmatic guide for diagnosis, management and care. Int J Gynaecol Obstet 131:S173–211CrossRef Hod M, Kapur A, Sacks DA, Hadar E, Agarwal M, Di Renzo GC et al (2015) The International Federation of Gynecology and Obstetrics Initiative on gestational diabetes mellitus: a pragmatic guide for diagnosis, management and care. Int J Gynaecol Obstet 131:S173–211CrossRef
17.
Zurück zum Zitat Sacks DA, Hadden DR, Maresh M, Deerochanawong C, Dyer AR, Metzger BE et al (2012) Frequency of gestational diabetes mellitus at collaborating centres based on IADPSG consensus panel-recommended criteria: the hyperglycemia and adverse pregnancy outcome (HAPO) Study. Diabetes Care 35:526–528CrossRef Sacks DA, Hadden DR, Maresh M, Deerochanawong C, Dyer AR, Metzger BE et al (2012) Frequency of gestational diabetes mellitus at collaborating centres based on IADPSG consensus panel-recommended criteria: the hyperglycemia and adverse pregnancy outcome (HAPO) Study. Diabetes Care 35:526–528CrossRef
18.
Zurück zum Zitat Vandorsten JP, Dodson WE, Espeland MA, Grobman WA, Guise JM, Mercer BM et al (2013) Diagnosing gestational diabetes mellitus. Natl Inst Health Consensus State Sci Statements 29:1–31 Vandorsten JP, Dodson WE, Espeland MA, Grobman WA, Guise JM, Mercer BM et al (2013) Diagnosing gestational diabetes mellitus. Natl Inst Health Consensus State Sci Statements 29:1–31
20.
Zurück zum Zitat Landon M, Spong CY, Thom E, Carpenter MW, Ramin SM, Casey B et al (2009) A Multicenter Randomized Trial of Treatment for Mild Gestational Diabetes. N Engl J Med 361:1339–1348CrossRef Landon M, Spong CY, Thom E, Carpenter MW, Ramin SM, Casey B et al (2009) A Multicenter Randomized Trial of Treatment for Mild Gestational Diabetes. N Engl J Med 361:1339–1348CrossRef
21.
Zurück zum Zitat Meek CL, Lewis HB, Patient C, Murphy HR, Simmons D (2015) Diagnosis of gestational diabetes mellitus: falling through the net. Diabetologia 58:2003–2012CrossRef Meek CL, Lewis HB, Patient C, Murphy HR, Simmons D (2015) Diagnosis of gestational diabetes mellitus: falling through the net. Diabetologia 58:2003–2012CrossRef
22.
Zurück zum Zitat Djelmis J, Pavic M, Kotori V, Renar I, Ivanisevic M, Oreskovic S (2016) Prevalence of gestational diabetes mellitus according to IADPSG and NICE criteria. Int J Gynecol obstet 135:250–254CrossRef Djelmis J, Pavic M, Kotori V, Renar I, Ivanisevic M, Oreskovic S (2016) Prevalence of gestational diabetes mellitus according to IADPSG and NICE criteria. Int J Gynecol obstet 135:250–254CrossRef
23.
Zurück zum Zitat Bhatia M, Mackillop LH, Bartlett K, Loerup L, Kenworthy Y, Levy J et al (2018) Clinical implications of the NICE 2015 criteria for gestational diabetes mellitus. J Clin Med 7:376CrossRef Bhatia M, Mackillop LH, Bartlett K, Loerup L, Kenworthy Y, Levy J et al (2018) Clinical implications of the NICE 2015 criteria for gestational diabetes mellitus. J Clin Med 7:376CrossRef
24.
Zurück zum Zitat Adam S, Rheeder P (2017) Screening for gestational diabetes mellitus in a South African population: revalence, comparison of diagnostic criteria and the role of risk factors. S Afr Med J 107:523–527CrossRef Adam S, Rheeder P (2017) Screening for gestational diabetes mellitus in a South African population: revalence, comparison of diagnostic criteria and the role of risk factors. S Afr Med J 107:523–527CrossRef
25.
Zurück zum Zitat Avalos GE, Owens LA, Dunne F, ATLANTICDIP Collaborators (2013) Applying current screening tools for gestational diabetes mellitus to a European Population: is it time for change? Diabetes Care 36:3040–3044CrossRef Avalos GE, Owens LA, Dunne F, ATLANTICDIP Collaborators (2013) Applying current screening tools for gestational diabetes mellitus to a European Population: is it time for change? Diabetes Care 36:3040–3044CrossRef
26.
Zurück zum Zitat Nayak PK, Mitra S, Sahoo JP, Daniel M, Mathew A, Padma A (2013) Feto-maternal outcomes in women with and without gestational diabetes mellitus according to the International Association of Diabetes and Pregnancy Study Groups (IADPSG) diagnostic criteria. Diabetes Metab Syndr 7:206–209CrossRef Nayak PK, Mitra S, Sahoo JP, Daniel M, Mathew A, Padma A (2013) Feto-maternal outcomes in women with and without gestational diabetes mellitus according to the International Association of Diabetes and Pregnancy Study Groups (IADPSG) diagnostic criteria. Diabetes Metab Syndr 7:206–209CrossRef
27.
Zurück zum Zitat Arora GP, Thaman RG, Prasad RB, Almgren P, Brons C, Groop LC et al (2015) Prevalence and risk factors of gestational diabetes in Punjab, North India: results from a population screening program. Eur J Endocrinol 173:257–267CrossRef Arora GP, Thaman RG, Prasad RB, Almgren P, Brons C, Groop LC et al (2015) Prevalence and risk factors of gestational diabetes in Punjab, North India: results from a population screening program. Eur J Endocrinol 173:257–267CrossRef
28.
Zurück zum Zitat Gopalakrishnan V, Singh R, Pradeep Y, Kapoor D, Rani AK, Pradhan S et al (2015) Evaluation of the prevalence of gestational diabetes mellitus in North Indians using the International Association of Diabetes and Pregnancy Study Groups (IADPSG) criteria. J Postgrad Med 61:155–158CrossRef Gopalakrishnan V, Singh R, Pradeep Y, Kapoor D, Rani AK, Pradhan S et al (2015) Evaluation of the prevalence of gestational diabetes mellitus in North Indians using the International Association of Diabetes and Pregnancy Study Groups (IADPSG) criteria. J Postgrad Med 61:155–158CrossRef
Metadaten
Titel
Comparison of criteria of International Association of Diabetes and Pregnancy Study Groups (IADPSG) with National Institute for Health and Care Excellence (NICE) for diagnosis of gestational diabetes mellitus
verfasst von
Sushila Todi
Haritha Sagili
Sadish Kumar Kamalanathan
Publikationsdatum
09.05.2020
Verlag
Springer Berlin Heidelberg
Erschienen in
Archives of Gynecology and Obstetrics / Ausgabe 1/2020
Print ISSN: 0932-0067
Elektronische ISSN: 1432-0711
DOI
https://doi.org/10.1007/s00404-020-05564-9

Weitere Artikel der Ausgabe 1/2020

Archives of Gynecology and Obstetrics 1/2020 Zur Ausgabe

Mammakarzinom: Brustdichte beeinflusst rezidivfreies Überleben

26.05.2024 Mammakarzinom Nachrichten

Frauen, die zum Zeitpunkt der Brustkrebsdiagnose eine hohe mammografische Brustdichte aufweisen, haben ein erhöhtes Risiko für ein baldiges Rezidiv, legen neue Daten nahe.

Mehr Lebenszeit mit Abemaciclib bei fortgeschrittenem Brustkrebs?

24.05.2024 Mammakarzinom Nachrichten

In der MONARCHE-3-Studie lebten Frauen mit fortgeschrittenem Hormonrezeptor-positivem, HER2-negativem Brustkrebs länger, wenn sie zusätzlich zu einem nicht steroidalen Aromatasehemmer mit Abemaciclib behandelt wurden; allerdings verfehlte der numerische Zugewinn die statistische Signifikanz.

Blutdrucksenkung könnte Uterusmyome verhindern

Frauen mit unbehandelter oder neu auftretender Hypertonie haben ein deutlich erhöhtes Risiko für Uterusmyome. Eine Therapie mit Antihypertensiva geht hingegen mit einer verringerten Inzidenz der gutartigen Tumoren einher.

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.